Business Context and Reporting Period
This Form 6-K filing by Chanson International Holding covers the month of June 2025. The report details the pricing and closing of a best efforts public offering of units, which was priced on June 13, 2025, and closed on June 16, 2025.
Key Financial Metrics
- Gross Proceeds: $8 million from the sale of 16,000,000 units at $0.50 per unit.
- Placement Agent Fees: 7.5% of gross proceeds in cash fees, plus a 1% non-accountable expense allowance.
- Other Expenses: Reimbursement for legal fees and out-of-pocket costs up to $150,000.
- Warrant Exercise Price: $0.525 per share for both Series A and Series B warrants.
- Pre-Funded Warrant Exercise Price: $0.0001 per share.
The filing text does not provide clear values for revenue, profit, cash flow, margins, or existing debt levels, as this report focuses solely on the capital raise transaction.
Material Changes
The primary material change is the increase in equity capital through the issuance of 16,000,000 units. Each unit consists of one Class A ordinary share (or a pre-funded warrant), one Series A warrant, and one Series B warrant. This transaction significantly alters the company's capital structure and potential share count due to the warrant components.
Guidance, Outlook, and Risks
- Use of Proceeds: Net proceeds are intended to open new stores in China and the U.S., with allocation based on market conditions.
- Lock-Up Agreements: The Company, its directors, executive officers, and beneficial owners of 5% or more of outstanding shares are subject to a 90-day lock-up period from the closing date.
- Warrant Provisions: Series A and Series B warrants are exercisable immediately and expire 2.5 years after issuance. They include cashless exercise provisions if no effective registration statement exists. Series B warrants include a "zero exercise price option" allowing for the issuance of up to 75,000,000 shares in aggregate.
- Beneficial Ownership Limits: Pre-Funded Warrants cannot be exercised if the holder would beneficially own more than 4.99% (or up to 9.99% at election) of outstanding shares.
Investor Verification Checklist
- Verify the final net proceeds after deducting the 7.5% placement fee, 1% expense allowance, and the up to $150,000 in reimbursable costs.
- Confirm the exact number of Class A Ordinary Shares issued versus Pre-Funded Warrants sold, as the share count decreases one-for-one for each Pre-Funded Warrant sold.
- Review the specific terms of the "zero exercise price option" for Series B Warrants to understand potential dilution risks.
- Monitor the allocation of funds between the China and U.S. markets as the company executes its store expansion plan.